KEMRI-Wellcome Trust Research Programme

KEMRI-Wellcome Trust Research Programme
Name	KEMRI-Wellcome Trust Research Programme
Founded	1989
Location	Kilifi, Nairobi, Kenya

KEMRI-Wellcome Trust Research Programme is a biomedical research institution based in Kenya that focuses on infectious diseases, epidemiology, clinical trials, and public health interventions. The Programme operates within a network of African, European, and global partners and conducts field studies, laboratory science, and health systems research. It engages with communities, national ministries, and international agencies to translate research into policy and practice.

History

The Programme traces its origins to collaborations between the Kenya Medical Research Institute and the Wellcome Trust during the late 20th century, building on precedents set by institutions such as the Rockefeller Foundation, Imperial College London, University of Oxford, and London School of Hygiene & Tropical Medicine. Early projects leveraged experience from Walter Reed Army Institute of Research, Centers for Disease Control and Prevention, and research linked to Malaria Vaccine Development Programme efforts. Founding activities intersected with regional health initiatives involving the Ministry of Health (Kenya), African Union, and networks like the African Academy of Sciences. Over time the Programme expanded through partnerships with universities including University of Nairobi, Kenyatta University, University of Cambridge, and international funders such as the Bill & Melinda Gates Foundation and the European & Developing Countries Clinical Trials Partnership.

Research Focus and Programs

Research spans pathogen-focused studies on Plasmodium falciparum, Plasmodium vivax, Mycobacterium tuberculosis, HIV/AIDS, SARS-CoV-2, Ebola virus, and Zika virus, alongside non-communicable disease intersections exemplified by work on diabetes mellitus and hypertension. Programs include clinical trials aligned with regulatory frameworks from bodies like the Food and Drug Administration and European Medicines Agency, vaccine efficacy studies connected to Gavi, the Vaccine Alliance, and antimicrobial resistance projects related to guidance from the World Health Organization. Epidemiological surveillance integrates tools developed by partners such as Wellcome Trust Sanger Institute, Public Health England, and the London School of Hygiene & Tropical Medicine. The Programme also conducts vector biology research linked to the Bill & Melinda Gates Foundation malaria initiatives and genetic studies that draw on capacity at the European Molecular Biology Laboratory and Broad Institute.

Facilities and Collaborations

Main campuses and field sites are located near Kilifi County and in Nairobi, with laboratory accreditation consistent with Good Clinical Laboratory Practice and collaborations with clinical centers like Kilifi County Hospital, Mombasa County Referral Hospital, and referral institutions such as Aga Khan University Hospital. The Programme maintains sequencing and bioinformatics capacity through links to institutions including Wellcome Sanger Institute, European Bioinformatics Institute, Max Planck Society, and the Institute Pasteur. Collaborative networks encompass global partners such as World Health Organization, UNICEF, Médecins Sans Frontières, PATH (nonprofit), and research consortia like the Global Fund-supported initiatives and the INDEPTH Network.

Governance and Funding

Governance structures involve stakeholder representation from entities like the Kenya Medical Research Institute, the Wellcome Trust, and governance models reflecting standards from bodies such as the National Institutes of Health, the Joint United Nations Programme on HIV/AIDS, and the African Union Commission. Funding streams have historically included grants from the Wellcome Trust, the Bill & Melinda Gates Foundation, the European Commission, and philanthropic support from organizations like the Wellcome Trust Institutional Strategic Support Fund and multilateral sources such as the World Bank. Ethical oversight aligns with committees modeled on the Kenya National Ethics Review Committee and international institutional review boards comparable to those at University of Oxford and Harvard University.

Impact and Contributions

The Programme has contributed to advances in malaria vaccine trials, tuberculosis diagnostics, HIV prevention strategies including studies informing PEP and PrEP implementation, and responses to outbreaks such as Ebola virus epidemic in West Africa and the COVID-19 pandemic. Outputs have influenced national policy at the Ministry of Health (Kenya), informed guidelines from World Health Organization, and contributed data to global initiatives like Gavi, the Vaccine Alliance and the Global Fund to Fight AIDS, Tuberculosis and Malaria. Research findings have been published in journals associated with institutions such as The Lancet, Nature, Science (journal), and BMJ, and have informed international clinical trial networks including ISRCTN Registry and ClinicalTrials.gov.

Training and Capacity Building

Training programs partner with universities and institutes like University of Oxford, London School of Hygiene & Tropical Medicine, University of Nairobi, and regional centers such as Makerere University and University of Cape Town. Capacity building includes postgraduate fellowships, laboratory technician training modeled on standards from the European Centre for Disease Prevention and Control, and short courses in epidemiology linked to the Africa CDC and the Wellcome Trust Academy. The Programme supports career development pathways comparable to schemes at Wellcome Trust Sanger Institute, Howard Hughes Medical Institute, and the National Institutes of Health.

Category:Medical research institutes in Kenya Category:International scientific organizations